• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Grading ovarian tumors. Evaluation of decision making by different pathologists.

作者信息

Baak J P, Delemarre J F, Langley F A, Talerman A

出版信息

Anal Quant Cytol Histol. 1986 Dec;8(4):349-53.

PMID:3814302
Abstract

Although grading of ovarian tumors is widely performed, the criteria for each grade are not well defined; as a result, pathologists tend to establish their own criteria without, however, assessing the actual predictive value of the criteria. In order to investigate this relationship, four gynecologic pathologists independently reviewed and carefully graded as benign, borderline or malignant (grade I, II or III) 40 "common" epithelial tumors of the ovary, without reference to clinical, prognostic or other findings. Intermediate grades were allowed. Subsequently, a subjective grading form was completed for each case; the form contained questions regarding the histologic and cytologic features. The sets of features with the biggest correlation with the tumor grades differed among the pathologists. This may indicate that the observers use different features in their grading processes. Moreover, the pathologist with the highest number (five) of significant microscopic features in the multivariate model had the lowest coefficient of correlation between his tumor grade and his feature set. The correlation coefficients for the other pathologists were quite similar, although the features used (no more than two or three) varied. The participants in the study felt that the methodologic approach had an educational value for them. Further investigations are required to evaluate whether the differences in the underlying decision making process also result in frank disagreement in ovarian tumor grading.

摘要

相似文献

1
Grading ovarian tumors. Evaluation of decision making by different pathologists.
Anal Quant Cytol Histol. 1986 Dec;8(4):349-53.
2
Interpathologist and intrapathologist disagreement in ovarian tumor grading and typing.病理学家之间以及同一病理学家内部在卵巢肿瘤分级和分型上的分歧。
Anal Quant Cytol Histol. 1986 Dec;8(4):354-7.
3
Pathological classification and grading of primary ovarian carcinoma: experience of the ARTAC ovarian study group.原发性卵巢癌的病理分类与分级:ARTAC卵巢研究组的经验
Bull Cancer. 1993 Feb;80(2):135-41.
4
The prognostic variability of ovarian tumor grading by different pathologists.
Gynecol Oncol. 1987 Jun;27(2):166-72. doi: 10.1016/0090-8258(87)90289-7.
5
Tumor cell type can be reproducibly diagnosed and is of independent prognostic significance in patients with maximally debulked ovarian carcinoma.肿瘤细胞类型能够被重复性诊断,并且在接受最大程度肿瘤细胞减灭术的卵巢癌患者中具有独立的预后意义。
Hum Pathol. 2008 Aug;39(8):1239-51. doi: 10.1016/j.humpath.2008.01.003. Epub 2008 Jul 7.
6
Observer disagreement in histological classification of ovarian tumors in Japan.
Gynecol Oncol. 1994 Jul;54(1):54-8. doi: 10.1006/gyno.1994.1165.
7
Interobserver and intraobserver variability of a two-tier system for grading ovarian serous carcinoma.卵巢浆液性癌分级的两级系统的观察者间及观察者内变异性
Am J Surg Pathol. 2007 Aug;31(8):1168-74. doi: 10.1097/PAS.0b013e31803199b0.
8
Validation of the histologic grading for ovarian clear cell adenocarcinoma: a retrospective multi-institutional study by the Japan Clear Cell Carcinoma Study Group.卵巢透明细胞腺癌组织学分级的验证:日本透明细胞癌研究组的回顾性多机构研究。
Int J Gynecol Pathol. 2011 Mar;30(2):129-38. doi: 10.1097/PGP.0b013e3181f71264.
9
[Ovarian epithelial tumors of borderline malignancy].
Rinsho Byori. 1992 Feb;40(2):119-31.
10
Importance of histologic grading in the prognosis of epithelial ovarian carcinoma.
Obstet Gynecol. 1982 May;59(5):576-82.

引用本文的文献

1
Strengthening the AntiTumor NK Cell Function for the Treatment of Ovarian Cancer.增强抗肿瘤自然杀伤细胞功能治疗卵巢癌。
Int J Mol Sci. 2019 Feb 19;20(4):890. doi: 10.3390/ijms20040890.
2
NGS-based BRCA1/2 mutation testing of high-grade serous ovarian cancer tissue: results and conclusions of the first international round robin trial.基于二代测序的高级别浆液性卵巢癌组织BRCA1/2基因突变检测:首次国际比对试验的结果与结论
Virchows Arch. 2016 Jun;468(6):697-705. doi: 10.1007/s00428-016-1919-8. Epub 2016 Mar 22.
3
The transcriptomic profile of ovarian cancer grading.
卵巢癌分级的转录组概况。
Cancer Med. 2015 Jan;4(1):56-64. doi: 10.1002/cam4.343. Epub 2014 Oct 15.
4
Survival in women with grade 1 serous ovarian carcinoma.1 级浆液性卵巢癌患者的生存情况。
Obstet Gynecol. 2013 Aug;122(2 Pt 1):225-232. doi: 10.1097/AOG.0b013e31829ce7ec.
5
Reclassification of serous ovarian carcinoma by a 2-tier system: a Gynecologic Oncology Group Study.采用 2 级系统对浆液性卵巢癌进行重新分类:一项妇科肿瘤学组研究。
Cancer. 2012 Jun 15;118(12):3087-94. doi: 10.1002/cncr.26618. Epub 2011 Nov 9.
6
Long-term survival of young women receiving fertility-sparing surgery for ovarian cancer in comparison with those undergoing radical surgery.年轻女性接受保留生育功能的卵巢癌手术与接受根治性手术的长期生存比较。
Br J Cancer. 2011 Oct 25;105(9):1288-94. doi: 10.1038/bjc.2011.394. Epub 2011 Oct 4.